<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 10-Q

(Mark One)
[X]  Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange
Act of 1934 For the quarterly period ended December 31, 1997 or
                                           -----------------
[  ]  Transition report pursuant to section 13 or 15(d) of the Securities
Exchange Act of 1934

For the Transition period from            to
                               ----------   ----------

                        Commission File Number :  0-19758

                               Access Health, Inc.
             (Exact name of registrant as specified in its charter)

               Delaware                                    68-0163589
    (State or other jurisdiction of                     (I.R.S. Employer
    incorporation or organization)                      Identification No.)

  310 Interlocken Parkway, Ste. A, Broomfield, CO           80021
  (Address of principal executive offices)                (Zip code)

                                  (303) 466-9500
              (Registrant's telephone number, including area code)


     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                    Yes X                         No
                       ---                          ---

Number of shares of Common Stock Outstanding at January 31, 1998: 18,643,345
shares

<PAGE>


                               Access Health, Inc.

                                      INDEX


                                                                  Page No.
                                                                  --------
 PART I    FINANCIAL INFORMATION

   Item 1.  Financial Statements

     Condensed consolidated balance sheets - September 30, 1997
      and December 31, 1997 . . . . . . . . . . . . . . . . . . . .      4

     Condensed consolidated statements of income - three months
      ended December 31, 1996 and 1997  . . . . . . . . . . . . . .      5

     Condensed consolidated statements of cash flows - three months
      ended December 31, 1996 and 1997  . . . . . . . . . . . . . .      6

     Notes to condensed consolidated financial statements . . . . .      7

   Item 2.  Management's discussion and analysis of financial
     condition and results of operations  . . . . . . . . . . . . .     10

 PART II.     OTHER INFORMATION

   Item 6. Exhibits and Reports on Form 8-K . . . . . . . . . . . .     17

 SIGNATURE  . . . . . . . . . . . . . . . . . . . . . . . . . . . .     18


                                        2


<PAGE>



                         PART 1.  FINANCIAL INFORMATION





















                                        3
<PAGE>

                               Access Health, Inc.
                      Condensed Consolidated Balance Sheets
               (In thousands, except per share and share amounts)


<TABLE>
<CAPTION>

                                                     September 30, December 31,
                                                         1997          1997
                                                     ------------- ------------
                                                      (Audited)     (Unaudited)
  <S>                                                <C>           <C>
  Assets:
  Current assets:
   Cash and equivalents  . . . . . . . . . . . . . .  $ 15,991      $  23,462
   Available-for-sale securities . . . . . . . . . .    41,969         44,594
   Accounts and license fees receivable, net of         12,453         14,342
    allowance for doubtful accounts of $963 ($768 at  
    September 30, 1997)  . . . . . . . . . . . . . .  
   Deferred income taxes   . . . . . . . . . . . . .     5,012          5,012
   Income taxes receivable . . . . . . . . . . . . .     3,231          3,220
   Prepaid expenses                                      2,122          2,136
   Other  current assets . . . . . . . . . . . . . .     1,448          1,111
                                                      ------------ ------------
                                                      
    Total current assets . . . . . . . . . . . . . .    82,226         93,877
  Property and equipment, net. . . . . . . . . . . .    16,150         16,413
  Purchased intangibles, net of accumulated              2,894          2,791
   amortization of $5,014 ($4,911 at September 30,    
   1997) . . . . . . . . . . . . . . . . . . . . . .  
  Deferred income taxes. . . . . . . . . . . . . . .     1,042          1,042
  Other assets . . . . . . . . . . . . . . . . . . .       342            380
                                                      ------------ ------------
                                                      $102,654       $114,503
                                                      ------------ ------------
                                                      ------------ ------------
                                                      
 Liabilities and Stockholders' Equity                 
  Current liabilities:                                
   Accounts payable  . . . . . . . . . . . . . . . .  $  3,634       $  4,533
   Accrued payroll and related expenses  . . . . . .     3,664          3,538
   Accrued integration and restructuring costs           3,109          2,538
   Taxes and other accrued expenses  . . . . . . . .     4,360          7,910
   Notes payable to related parties  . . . . . . . .     1,264            315
   Current portion of long-term debt   . . . . . . .       198            203
   Current portion of capital lease obligation.            457            470
   Deferred revenues . . . . . . . . . . . . . . . .     4,954          5,184
                                                      ------------ ------------
    Total current liabilities  . . . . . . . . . . .    21,640         24,691
  Capital lease obligations  . . . . . . . . . . . .       481            348
  Long-term debt . . . . . . . . . . . . . . . . . .       197            145
                                                      
  Commitments and contingencies                       
  Stockholders' equity:                               
   Preferred stock, $.001 par value- 5,000,000 shares 
    authorized, no shares issued and outstanding   .          -             -
   Common stock, $.001 par value-75,000,000 shares    
    authorized, 18,564,697 shares issued and          
    outstanding (18,246,159 at September 30, 1997) .         18            19
   Additional paid-in capital  . . . . . . . . . . .     80,806        84,374
   Retained earnings   . . . . . . . . . . . . . . .       (488)        4,926
                                                      ------------ ------------
    Total stockholders' equity   . . . . . . . . . .     80,336        89,319
                                                      ------------ ------------
                                                       $102,654      $114,503
                                                      ------------ ------------
                                                      ------------ ------------
</TABLE>

                             See accompanying notes.

                                        4

<PAGE>

                               Access Health, Inc.
                   Condensed Consolidated Statements of Income
                    (In thousands, except per share amounts)
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                   Three months ended
                                                       December 31,
                                            ----------------------------------
                                                 1996               1997
                                            ----------------------------------
 <S>                                        <C>              <C>
 Revenues:
  Care management services . . . . . . . . $   21,872          $  26,321
  Licensing and support services . . . . .      2,769              2,728
                                           --------------    ----------------
   Total revenues  . . . . . . . . . . . .     24,641             29,049

 Costs and expenses:
  Cost of revenues:
   Care management services. . . . . . . .     11,040             14,405
   Licensing and support services. . . . .      1,128                675
  Product and other development. . . . . .      2,356              1,498
  Sales and marketing  . . . . . . . . . .      2,338              2,199
  General and administrative . . . . . . .      2,367              2,298
  Transaction costs  . . . . . . . . . . .      6,345                  -
  Integration and restructuring costs. . .      6,961                  -
                                           --------------    ----------------
   Total costs and expenses  . . . . . . .     32,535             21,075
                                           --------------    ----------------

 Income (loss) from operations . . . . . .     (7,894)             7,974

 Other income  . . . . . . . . . . . . . .        379                758
                                           --------------    ----------------

 Income (loss) before income taxes . . . .     (7,515)              8,732
 Provision (credit) for income taxes . . .     (1,503)              3,318
                                           --------------    ----------------

 Net income (loss) . . . . . . . . . . . . $   (6,012)           $  5,414
                                           --------------    ----------------
                                           --------------    ----------------

 Income (loss) per share
     Basic . . . . . . . . . . . . . . . . $    (0.34)           $    .29
                                           --------------    ----------------
                                           --------------    ----------------
     Diluted . . . . . . . . . . . . . . . $    (0.34)           $    .27
                                           --------------    ----------------
                                           --------------    ----------------
 Shares used in per share calculations
     Basic . . . . . . . . . . . . . . . .     17,570              18,425
     Diluted . . . . . . . . . . . . . . .     17,570              20,106
</TABLE>

                             See accompanying notes.


                                        5

<PAGE>

                               Access Health, Inc.
                 Condensed Consolidated Statements of Cash Flows
                   Increase (Decrease) in Cash and Equivalents
                                 (In thousands)
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                          Three months ended
                                                             December 31,
                                                     --------------------------
                                                         1996           1997
                                                     --------------------------
 <S>                                                 <C>              <C>
 Cash flows from operating activities:
  Net income (loss). . . . . . . . . . . . . . . . . $  (6,012)       $   5,414
  Adjustments to reconcile net income to net cash
   provided by operations:
   Allowance for doubtful accounts . . . . . . . . .         6               20
   Depreciation and amortization . . . . . . . . . .     1,338            1,735
   Deferred stock compensation . . . . . . . . . . .       443                -
   Common stock issued for services rendered . . . .     2,233                -
   Changes in:
     Accounts and licenses receivable  . . . . . . .       566           (1,909)
     Prepaid expenses and other current assets . . .       432              335
     Accounts payable  . . . . . . . . . . . . . . .      (547)             899
     Accrued payroll and related expenses  . . . . .      (170)            (126)
     Accrued integration and restructuring costs . .     6,186             (571)
     Other accrued expenses  . . . . . . . . . . . .    (1,393)           3,550
     Notes payable to related parties. . . . . . . .       515             (949)
     Deferred revenues . . . . . . . . . . . . . . .      (895)             230
                                                     -----------      ---------
         Net cash provided by operating activities .     2,702            8,628
                                                     -----------      ---------
 Cash flows from investing activities:
   Purchase of available-for-sale securities, net. .    (2,807)          (2,625)
   Purchase of property and equipment. . . . . . . .    (1,123)          (1,896)
   Other assets. . . . . . . . . . . . . . . . . . .      (155)             (38)
                                                     -----------      ---------
        Net cash used by investing activities. . . .    (4,085)          (4,559)
                                                     -----------      ---------

 Cash flows from financing activities:
   Payment of long-term debt and capital leases. . .      (116)            (166)
   Sale of common stock. . . . . . . . . . . . . . .       338            3,568
                                                     -----------      ---------
        Net cash provided by financing activities. .       222            3,402
                                                     -----------      ---------

 Net increase (decrease) in cash and equivalents . .    (1,161)           7,471
 Cash and equivalents at beginning of period . . . .    26,533           15,991
                                                     -----------      ---------

 Cash and equivalents at end of period . . . . . . . $  25,372        $  23,462
                                                     -----------      ---------
                                                     -----------      ---------
</TABLE>


                             See accompanying notes.

                                        6

<PAGE>

                                 Access Health, Inc.
                 Notes to Condensed Consolidated Financial Statements
                                  December 31, 1997
                                     (Unaudited)


Note 1:   Summary of Significant Accounting Policies

INTERIM FINANCIAL STATEMENTS

The accompanying consolidated condensed interim financial statements have been
prepared by the Company, without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission (the "Commission").  Certain information
and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles have been omitted
pursuant to such rules and regulations. The accompanying consolidated condensed
interim financial statements should be read in conjunction with the financial
statements and notes thereto included in the Company's Form 10-K for the fiscal
year ended September 30, 1997.

In the opinion of management the unaudited interim financial statements reflect
all adjustments, consisting of only normal recurring adjustments, necessary to
present fairly the Company's consolidated financial position at December 31,
1997, consolidated results of operations for the three month periods ended
December 31, 1996 and 1997 and cash flows for the three month periods ended
December 31, 1996 and 1997.  Results for the period ended December 31, 1997 are
not necessarily indicative of the results to be expected for the entire fiscal
year.

REVENUE RECOGNITION

Revenues include care management services, which consist of program membership,
member communications and teleservicing fees from the Company's Personal Health
Advisor/FirstHelp and ASK-A-NURSE contracts with managed care organizations,
self-insured employers and hospitals. Revenues also include licensing and
support services related to the Company's ASK-A-NURSE, FirstHelp, patient
education software, Access Care Management System, HealthSelect, and CANCER
HELPLINK. 

Program membership fees from Personal Health Advisor and FirstHelp contracts are
recognized ratably in accordance with contract terms typically on the basis of
per-member fees. Member communications fees are recognized upon the delivery of
services.  Teleservicing fees are recognized in accordance with contract terms
on the basis of per-call fees or fees based on phone counselor staffing.

License revenues from ASK-A-NURSE, FirstHelp, and CANCER Helplink products are
recognized ratably over the term of the contract. HealthSelect and patient
education software revenue is recognized upon delivery of the software. Support
revenues are comprised of ASK-A-NURSE, CANCER HELPLINK, and Access Care
Management System support revenue, LIFE MATCH software support revenue and
direct marketing fees. Revenue from support contracts and software maintenance
contracts is recognized ratably over the contract term. Direct marketing fees
are recognized upon the delivery of services.

PRODUCT AND OTHER DEVELOPMENT COSTS
     
Product and other development costs are expensed as incurred and consist
primarily of salaries, supplies and contract services related to the development
of the Company's products and services.


                                          7
<PAGE>

TRANSACTION COSTS AND INTEGRATION AND RESTRUCTURING COSTS

Transaction costs of $6.3 million reflect charges associated directly with the
merger of the Company with Informed Access and CRS and included professional
fees of approximately $5.2 million. Also related to the mergers were integration
and restructuring costs recorded in the first and fourth quarters of fiscal
1997, which included approximately $6.3 million for severance and related
expenses, approximately $400,000 for elimination of redundant technology,
approximately $1.2 million for discontinuation of facilities, approximately
$900,000 for disposal of assets and approximately $900,000 for relocation and
other costs.

New Accounting Pronouncements

STATEMENT OF ACCOUNTING STANDARDS NO. 128

For the quarter ended December 31, 1997, the Company adopted Financial
Accounting Standards Board  Statement 128 to report earnings per share. Basic
EPS is calculated based upon the weighted average of actual shares outstanding.
Diluted earnings per share is most similar to  what was reported as earnings per
share under Accounting Principles Board Opinion ("APB") No. 15 which includes
the dilutive impact of stock options using the treasury stock method. 

STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 130

In June 1997, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 130, "Reporting Comprehensive Income, " which
is required to be adopted for fiscal years beginning after December 15, 1997.
This statement establishes standards for reporting and display of comprehensive
income and its components in a full set of general-purpose financial statements.
This statement requires that all items that are required to be recognized under
accounting standards as components of comprehensive income  be reported  in a
financial statement that is displayed with the same prominence as other
financial statements. Reclassification of financial statements for earlier
periods provided for comparative purposes is required. The Company expects to
adopt Statement No. 130 in the first quarter of fiscal 1999.

STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 131

In June 1997, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 131, "Disclosures about Segments of an
Enterprise and Related Information, " effective for fiscal years beginning after
December 15, 1997. This statement requires that a public company report
financial and descriptive information about its reportable operating segments
using the management approach. The Company expects to adopt Statement No. 131 in
the first quarter of fiscal 1999.

Note 2:  Business combinations

During November 1996 the Company consummated business combinations with Informed
Access which included the exchange of 5,375,000 shares of Access Health common
stock (including 4,778,317 shares issued to Informed Access shareholders and
596,683 shares reserved for future grant to Informed Access option holders) and
CRS, which included the exchange of 170,000 shares of Access Health common
stock.  These business combinations were accounted for as pooling-of-interests
and, accordingly, the historical financial statements of the Company have been
restated to include the consolidated financial statements of Access Health,
Informed Access and CRS for all periods presented.


                                          8
<PAGE>

Note 3: Notes payable to related parties

Notes payable to related parties arising from bonuses are payable to members of
management, who are also stockholders of the Company. The final installment of
these notes was paid in January 1998.

Note 4:  Long-term debt

The Company has a term facility agreement ( the "Term Agreement") whereby
through December 1996, the Company could borrow, in one or more borrowings, an
amount not to exceed $2.0 million in the aggregate, subject to certain
conditions set forth in the Term Agreement.  At December 31, 1997,  borrowings
under the note payable facility and capital lease facility totaled $347,000 and
$601,000, respectively.  Borrowings under the Term Agreement are secured by
certain of the Company's equipment with an aggregate carrying value of
approximately $800,000 at December 31, 1997.  Amounts payable under the Term
Agreement bear interest at 14.48% , are due at varying dates through September
1999, and require monthly payments of principal and interest totaling
approximately $52,000.  Amount due under the note payable facility of the Term
Agreement for the next twelve months is approximately $531,000. 

Note 5: Income taxes

The Company's state net operating loss carryforwards of approximately $6.7
million as of September 30, 1997 expire between 2007 and 2011. The Company also
has approximately $161,000 of federal research and development tax credits
available, which expire between 2007 and 2011. 

Realization of the Company's net deferred tax assets is dependent upon the
Company generating sufficient taxable income in future years in the appropriate
tax jurisdiction to obtain benefit from the reversal of temporary differences
and from tax credit and net operating loss carryforwards. The amount of deferred
tax assets considered realizable is subject to adjustment in future periods if
estimates of future taxable income are reduced.

Note 6:  Commitments

OPERATING LEASES

The Company leases its offices under the terms of operating leases that expire
between September 1998 and  December 2012. Annual minimum rental payments for
fiscal 1998, 1999, 2000, 2001, 2002 and thereafter are $3,032,000, $2,920,000,
$2,695,000, $2,641,000, $1,597,000 and $17,381,000 respectively. Rental expenses
are recorded on a straight-line basis over the respective lease terms.

Note 7:  Subsequent Event

As of February 17, 1998, the Company announced a definitive agreement to 
acquire privately held InterQual, Inc. of Marlborough, Massachusetts. 
InterQual is the leading provider of clinical decision support criteria to 
health care insurers, plans and providers. The transaction will be accounted 
for as a pooling of interests under APB Opinion No. 16 and is expected to 
close in the second calendar quarter of this year. The merger transaction is 
subject to stockholder approval by both companies and customary closing 
conditions.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS WHICH INVOLVE RISKS AND
UNCERTAINTIES.  THE COMPANY'S ACTUAL RESULTS COULD DIFFER MATERIALLY FROM THE
RESULTS ANTICIPATED IN THESE FORWARD-LOOKING STATEMENTS AS A RESULT OF CERTAIN
FACTORS SET FORTH HEREUNDER AND IN THE COMPANY'S ANNUAL REPORT AS FILED ON FORM
10-K.


                                          9
<PAGE>

GENERAL.  The Company completed mergers with Informed Access Systems, Inc.
("Informed Access") and Clinical Reference Systems, LTD ("CRS") during November
1996.  Both transactions were accounted for as pooling-of-interests and,
accordingly, Management's Discussion and Analysis of Financial Condition and
Results of Operations refers to the historical financial statements of the
Company that have been restated to include the consolidated financial statements
of Access Health, Informed Access and CRS, and the combined results of
operations and financial position of all three companies for the first quarter
of fiscal 1997.

RESULTS OF OPERATIONS

REVENUES.  Revenues consist of revenues from care management services and
licensing and support services.  Revenues increased from $24.6 million during
the three months ended December 31, 1996 to $29.0 million during the three
months ended December 31, 1997.

Revenues from care management services increased from $21.9 million during the
first quarter of fiscal 1997 to $26.3 million during the first quarter of fiscal
1998 due to increases in membership levels related to the Company's contracts
during these periods. As of December 31, 1997, approximately 23.1 million
members were enrolled compared to approximately 16.5 million members enrolled as
of December 31, 1996. Revenue from the Company's contracts is recognized ratably
in accordance with contract terms on the basis of per-member fees.

Revenues from licensing and support services decreased slightly from
$2.8 million during the first quarter of fiscal 1997 to $2.7 million during the
first quarter of fiscal 1998. Licensing and support services revenues include
licensing implementations and program support activities for FirstHelp, the
ASK-A-NURSE-Registered Trademark- family of products, CANCER HelpLink-Registered
Trademark-, Access Care Management System-Registered Trademark- ("ACMS") and the
LIFE MATCH-Registered Trademark-family of products.

COST OF REVENUES.  The cost of care management services revenues includes the
costs of operating the Company's services centers, on-going client consultation
and charges for providing care management member communications services. The
gross margins for care management services were 49.5% during the first quarter
of fiscal 1997 and 45.3% during the first quarter of fiscal 1998. Gross margin
for personal health management services decreased during the three month period
ended December 31, 1997, compared to the same period in the prior year, due
primarily to rolling out a common service platform to all call centers,
absorbing the costs associated with new product beta sites and adjusting pricing
on older contracts. 

The cost of licensing and support services revenues includes the costs of
license implementations, on-going client consultation, annual users'
conferences, advertising materials, and other support services for FirstHelp, 
ASK-A-NURSE, CANCER HelpLink, Access Care Management System ("ACMS") and LIFE
MATCH licensees. The gross margin percentages for licensing and support services
increased from 59.3% during the first quarter of fiscal 1997 to 75.3% during the
first quarter of fiscal 1998 due to changes in product licensing mix and
increased efficiency resulting from organizational adjustments. While gross
margins for licensing and support can fluctuate, the Company believes it is
operating near targeted gross margin levels for licensing and support services.

PRODUCT AND OTHER DEVELOPMENT EXPENSES.  Product and other development 
expenses totaled $2.4 million, or 9.6% of revenues, during the first quarter 
of fiscal 1997 and $1.5 million, or 5.2% of revenues, during the first 
quarter of fiscal 1998. The decrease is due to the integration of the 
development teams of Access Health and Informed Access Systems. In order to 
meet consumer needs and demands for new products, the Company expects to 
continue to increase spending on development in future quarters.*

SALES AND MARKETING EXPENSES.  Sales and marketing expenses were $2.3 million,
or 9.5% of revenues, and $2.2 million, or 7.6% of revenues, during the first
quarter of fiscal 1997 and 1998, respectively. As a


                                          10
<PAGE>

percentage of revenue, sales and marketing expenses declined due to the
integration of the sales teams of Access Health and Informed Access. In future
periods, the Company expects to maintain a generally consistent relationship of
sales and marketing expenses to revenues.*

GENERAL AND ADMINISTRATIVE EXPENSES.  General and administrative expenses were
$2.4 million, or 9.6% of revenues, and $2.3 million, or 7.9% of revenues, during
the first quarter of fiscal 1997 and 1998, respectively. As a percent of
revenue, general and administrative expenses decreased due to the integration of
Access Health and Informed Access Systems' management teams. The Company expects
general and administrative expenses to increase in coming quarters, but
generally consistent with the current percentage of revenue.*

TRANSACTION COSTS.  Transaction costs of $6.3 million were one-time charges
recorded in the first quarter of fiscal 1997 associated directly with the merger
of the Company with Informed Access and CRS and consists primarily of
professional fees and services of approximately $5.2 million.

INTEGRATION AND RESTRUCTURING COSTS.  Related to the merger of Informed Access
and CRS, these one-time costs recorded in the first quarter of fiscal 1997
included approximately $3.0 million for severance and related expenses, $1.5
million for elimination of redundant technologies, and $1.5 million for
discontinued facilities.

INCOME FROM OPERATIONS.  Operating income increased from a loss of $7.9 million
during the first quarter of fiscal 1997 to a profit of $8.0 million during the
first quarter of fiscal 1998. As indicated above,  the change is attributable to
increasing revenues and decreased ongoing operating expenses, and to the
transaction, integration and restructuring expenses recorded in the first
quarter of fiscal 1997.

OTHER INCOME.  The Company generates interest and other income from cash
balances and available-for-sale securities. Interest and other income increased
from $379,000 to $758,000 in the first quarter of fiscal 1997 and 1998,
respectively due to the increase in cash and equivalents and available for sale
securities from $58.0 million at December 31, 1996 to $68.1 million at December
31, 1997. 

EFFECTS OF INFLATION AND CHANGING PRICES.  Inflation and changing prices have
not had a material effect on the Company's operations and, at current levels,
are not expected to in future years*. 

LIQUIDITY AND CAPITAL RESOURCES

As of December 31, 1997, the Company held cash and equivalents and
available-for-sale securities totaling $68.1 million compared to a balance of
$58.0 million as of September 30, 1997.  Cash provided by operations during the
first three months of fiscal 1998 was $8.6 million compared with $2.7 million
for the first three months of fiscal 1997.

The Company believes its current capital resources are adequate to fund cash
needs for anticipated operating levels for at least the next twelve months*. The
Company also may use capital resources in connection with business expansion
that may include the acquisition of complementary product lines or businesses
during fiscal 1998 or beyond*.

During the first three months of fiscal 1998, the Company purchased
approximately $1.9 million of property and equipment. The Company expects to
purchase additional capital equipment during the balance of fiscal 1998 to
further integrate and expand call centers and system capacity, and to expand the
Company's corporate infrastructure*.

* THIS STATEMENT IS A FORWARD-LOOKING STATEMENT REFLECTING CURRENT EXPECTATIONS.
THERE CAN BE NO ASSURANCE THAT THE COMPANY'S ACTUAL FUTURE PERFORMANCE WILL MEET
THE COMPANY'S CURRENT EXPECTATIONS.


                                          11
<PAGE>

INVESTORS ARE STRONGLY ENCOURAGED TO REVIEW THE SECTION ENTITLED "RISK FACTORS
THAT MAY AFFECT FUTURE OPERATING PERFORMANCE."

FACTORS THAT MAY AFFECT FUTURE OPERATING PERFORMANCE

ABILITY TO SECURE ADDITIONAL CONTRACTS AND EXPAND AND RETAIN EXISTING CONTRACTS.
The Company's ability to increase revenues and profitability is largely
dependent on the Company's ability to secure additional care management
contracts and to retain and expand existing contracts. The Company could be
adversely affected by the termination or non-renewal of any of the Company's
contracts, or by renegotiation of the terms of contracts, particularly if the
affected contracts cover a large number of members or represent a significant
portion of the Company's licensing and support revenue. Any factors adversely
affecting the market for the care management product or the licensing and
support services products, including factors outside of the Company's control,
such as adverse publicity or government regulatory action, could have a material
adverse effect on the Company.

DEPENDENCE ON PRINCIPAL CUSTOMERS. Significant portions of the Company's
revenues are generated by a limited number of customers. The Company's care
management contracts range from approximately 800 members to 3.0 million members
per contract. In fiscal 1997, the five largest single care management
enrollments total 3.0 million, 2.4 million, 1.9 million, 1.5 million and 1.5
million members. In fiscal 1997, the Company's three largest customers accounted
for approximately 8.0%, 7.8%, and 6.9% of the Company's total revenues and the
Company's top five customers, in the aggregate, accounted for approximately
33.4% of the Company's total revenues. After an initial term of approximately
one to four years, contracts generally can be terminated upon  60 to 360 days
notice to the Company. Three of the Company's  five largest contracts are up for
renewal in 1998. The Company's contracts could be subject to early termination
by its customers if the Company were not in compliance with any applicable
government regulation. The termination, non-renewal or renegotiation of any such
agreements could have a material adverse effect on the Company's operating
results. See "Government Regulation."

Uncertainty of future operating results. The Company's quarterly operating
results may fluctuate significantly in the future as a result of a variety of
factors, many of which are outside the Company's control. There can be no
assurance that the Company's revenues and profitability will increase during
fiscal 1998 and beyond. The Company's revenues may be materially adversely
affected by the termination or non-renewal of the Company's contracts or by the
renegotiation of the terms of such contracts. The Company may incur
significantly increased sales, marketing, and promotional expenses during fiscal
1998, and may devote additional resources  to the further development of care
management, disease management or other new products. To the extent that the
Company incurs increased expenses,  the Company's operating results will be
adversely affected unless revenues and operating margins increase sufficiently
to offset such expenditures. See "Management's Discussion and Analysis of
Financial Condition and Results of Operations."

COMPETITION.  The market for the Company's products and services is highly
competitive. There are a number of competitors that offer products or services
that compete with some or all of those offered by the Company. Existing and
potential clients may also evaluate the Company's products or services against
internally developed programs. Increased competition could result in pricing
pressure and margin erosion. In its existing business and as the Company offers
new products or services, or enters new markets, it may face increased
competition from competitors, some of which may have substantially greater
financial, marketing and technical resources than the Company. In particular,
several small competitors have recently been acquired or are expected to be
acquired by companies with substantially greater financial, marketing and
technical resources than the Company, and this could lead to increased
competition. There can be no assurance that the Company will continue to compete
successfully.


                                          12
<PAGE>

CHANGING HEALTH CARE MARKET AND NEW PRODUCT DEVELOPMENT.  The health care
industry has undergone significant changes in recent years, and changes are
expected to continue. Containing health care costs has become a national
priority. As a result, the health care industry has become increasingly
dominated by managed health care plans, causing cost containment pressure to
rise. To address these changes, the Company shifted its business focus in 1993
to payors from providers and developed its personal health management services.
There is no assurance that the Company's existing products and services will
achieve continued success or that its new products and services will succeed.
There also can be no assurance that continued industry change will not adversely
affect the Company's ability to compete. Continued change may cause the Company
to incur significant product development and marketing expenses. The Company's
future success will depend on the Company's ability to adapt to the changing
needs of the health care industry. 

CARE CENTER OPERATIONS.  The Company maintains member service and data centers
("care centers") in Rancho Cordova, California; Chicago, Illinois; Broomfield,
Colorado; and Phoenix, Arizona. The Company's operations depend on the adequate
functioning of the computer and telephone systems in its call centers. Although
the Company has taken precautions to provide for power, computer, and telephone
systems redundancy, there can be no assurance that a fire or other disaster
affecting the centers or an equipment failure would not disable the Company's
systems for a significant period of time. Any significant damage to the
Company's facilities or an equipment failure could have a material adverse
effect on the Company's results of operations. 

The successful operation of the Company's care centers is based on a networked
information system. The information system provides care center nurses and
health care counselors with access to care management applications and a
database of information including member information, plan rules, physician
information and clinical algorithms and guidelines. The Company is in the
process of developing a new information system which combines certain aspects of
the different systems developed by Access Health and Informed Access. Failure to
successfully develop and implement this new information system could delay
revenues or increase operating costs and could have a material adverse effect on
the Company. The ability to continue to develop, implement and support the
Company's information systems is dependent on its ability to employ and retain
experienced technical personnel. If the Company is unable to hire and retain
required personnel or is required to pay compensation at significantly higher
levels to attract and retain technical personnel it could have a material
adverse effect on the Company's financial results.

LIMITATIONS ON PROTECTION OF PROPRIETARY RIGHTS. The Company regards its
software, clinical algorithms and nursing assessment tools, clinical operational
expertise and marketing and program operation materials as proprietary and takes
action to protect its intellectual property with patents, copyrights,
trademarks, trade secret laws and restrictions on disclosure, copying and
transferring title. Despite the Company's precautions, it may be possible for
unauthorized third parties to copy aspects of the Company's products or to
obtain and use information that the Company regards as proprietary. There can be
no assurance that competitors, some of which have substantial resources and have
made substantial investments in competing technologies, will not seek to apply
for and obtain patents that will prevent, limit or interfere with the Company's
ability to market its products and services either in the United States or in
international markets. The Company could incur substantial costs defending
itself in suits against the Company or its proprietary rights or in bringing
suits against those parties to enforce the Company's proprietary rights. The
Company has been issued patents on its clinical algorithms in the United States
and has filed for patent protection in some foreign countries. There is no
assurance that such patents will not be challenged or invalidated. Existing
copyright laws afford only limited practical protection. In addition, the laws
of some foreign countries do not protect the Company's proprietary rights to the
same extent as do the laws of the United States, which could be a factor
depending upon into which countries outside the United States the Company
expands. 


                                          13
<PAGE>

MANAGEMENT OF GROWTH.  The Company has experienced rapid growth in recent years.
Continued rapid growth may place a significant strain on the Company's
management, telecommunications systems, operational infrastructure, working
capital and financial and management control systems.  The difficulties of
managing growth may be increased by the necessity of coordinating geographically
separated organizations. In order for the Company to manage its client base
successfully, management will be required to anticipate the changing demands of
their growing operations and to adopt systems and procedures accordingly. 
Failure to effectively implement or maintain such systems and procedures could
adversely affect the Company's business, results of operation and financial
condition.  Further, there can be no assurance that the Company's current
information systems, telecommunications systems and operational infrastructure
will be adequate for its future needs, or that the Company will be successful in
implementing new systems.  Failure to upgrade its information systems,
telecommunications systems and operational infrastructure or unexpected
difficulties encountered with these systems during expansion could adversely
affect the Company's business, financial condition and results of operations.

ACQUISITION-RELATED RISKS.   The Company has grown in part through mergers and
acquisitions. The Company intends to evaluate acquisitions of product lines and
businesses as part of its business strategy. The process of integrating an
acquired company's business into the Company's operations may result in
unforeseen operating difficulties and expenditures and may absorb significant
management attention that would otherwise be available for the ongoing
development of the Company's business.  Moreover, there can be no assurance that
the anticipated benefits of an acquisition will be realized.  Future
acquisitions by the Company could result in potentially dilutive issuance's of
equity securities, the incurrence of debt and contingent liabilities and
amortization expenses related to goodwill and other intangible assets, which
could materially adversely affect the Company's operating results and financial
condition.  In addition, acquisitions involve numerous risks, including
difficulties in managing diverse geographic operations, the diversion of
management's attention from other business concerns, risks of entering markets
in which the Company has no or limited direct prior experience and the potential
loss of key employees of the acquired company.  The inability of the Company's
management to respond to changing business conditions effectively, including the
changes associated with its acquired businesses and product lines, could have a
material adverse effect on the Company's results of operations.

KEY EMPLOYEES AND MANAGEMENT OF CHANGE.  The Company's success depends on a
limited number of key management employees, most of whom are subject to
post-employment non-competition restrictions. The loss of the services of one or
more of these employees could have a material adverse effect on the Company. The
Company believes that its continued success also will depend in large part on
its ability to attract and retain highly-skilled management, marketing, sales
and nursing personnel. Competition for such personnel is intense, and there can
be no assurance that the Company will be successful in attracting and retaining
such personnel as necessary. Furthermore, the Company's ability to manage change
and growth successfully will require the Company to continue to improve its
management expertise as well as its financial systems and controls.

VOLATILITY OF STOCK PRICE. The market for the Company's stock is highly
volatile. The trading price of Access Health's common stock is subject to wide
fluctuations in response to a variety of factors including the signing or loss
of a major contract, changes in market analyst estimates and recommendations for
the Company's common stock, fluctuations in operating results, the failure of
operating results to meet market analyst's estimates, changes in government
regulation and general conditions in the health care industry and the economy,
any of which could cause the price of the Company's common stock to fluctuate,
perhaps substantially. In addition, in recent years stock prices have
experienced significant fluctuations, which have particularly affected the
market price for the securities of health care companies and which often have
been unrelated to the operating performance of these companies.

GOVERNMENT REGULATION.  The health care industry is subject to extensive and
evolving government regulation at both the Federal and state levels relating to
many aspects of the Company's and its clients'


                                          14
<PAGE>

businesses in use of the Company's programs, including the provision of health
care services, teleservicing, and health care referral programs. These statutes
and regulations in many cases predate the development of telephone-based health
care information and other interstate transmission and communication of medical
information and services. The literal language of certain of these statutes and
regulations governing the provision of health care services, including the
practice of nursing and the practice of medicine, could be construed by
regulatory authorities to apply to certain of the Company's activities,
including without limitation teleservicing activities which use California,
Illinois, Arizona, and Colorado registered nurses to provide out-of-state care
management services such as nursing assessments and information regarding
appropriate sources of care and treatment time frames. These statutes and
regulations could also apply to certain activities of the Company's health
service customers when operating the Company's programs.  In addition, the
literal language of the statutes and regulations governing health maintenance
organizations and other plans that provide or arrange for the provision of
health care services for a prepaid or periodic charge could be construed by
regulatory authorities to apply to certain activities of the Company that are
provided on a per-member, per-month basis. The Company has not been made, nor is
it aware that any other company providing out-of-state teleservicing has ever
been made, the subject of such requirements by a regulatory authority. However,
if regulators seek to enforce any of the foregoing statutory and regulatory
requirements, the Company, its employees and/or its clients could be required to
obtain additional licenses or registrations, to modify or curtail the operation
of the Company's programs, to modify the method of payment for the Company's
programs, or to pay fines or incur other penalties. 

The payment of remuneration to induce the referral of health care business has
been a subject of increasing governmental and regulatory focus in recent years.
Section 1128B(b) of the Social Security Act (sometimes referred to as the
"Federal anti-kickback statute") provides criminal penalties for individuals or
entities that knowingly and willfully offer, pay, solicit or receive
remuneration in order to induce referrals for items or services for which
payment may be made under the Medicare and Medicaid programs and certain other
government-funded programs. The Social Security Act provides authority to the
Office of the Inspector General through civil proceedings to exclude an
individual or entity from participation in the Medicare and state health
programs if it is determined any such party has violated Section 1128B(b) of the
Social Security Act. Regulations have been promulgated specifying certain
payment practices, which will not be subject to criminal prosecution or civil
exclusion. These regulations, commonly referred to as the "safe harbor"
regulations, do not expand the scope of the Federal anti-kickback statute, and
the fact that a business arrangement does not fit within a safe harbor does not
mean the business arrangement violates the Federal anti-kickback statute. The
Company's programs do not meet the requirements of the safe harbor for referral
services. A number of states in which the Company operates have anti-kickback
statutes similar to the Federal statute as well as statutory and regulatory
requirements governing referral agencies and regulating franchising and business
opportunity ventures. In addition, the Federal government and a number of states
have enacted statutes which contain outright prohibitions on referrals for
specified services which are made by referring providers who have an ownership
interest in, or compensation arrangement with, the entity to which the referral
is made. If the Company or the use of its products and services were to be found
in violation of such statutes, the Company or its clients could be required to
modify or curtail the operation of the Company's programs, or to pay fines or
incur other penalties, and the Company's clients could be excluded from
participation in the Medicare and Medicaid programs and could be precluded from
charging fees and obtaining reimbursement for specified services. 

There can be no assurance that the Company or the use of its products and
services will not be subject to review or challenge by government regulators
under any of the foregoing statutes and regulations that apply to health care
services and products. In addition, additional laws and regulations could be
enacted in the future that would regulate the Company or the use of its products
and services. Any government investigative or enforcement actions with respect
to the Company or the use of its products or services could generate adverse
publicity irrespective of the final outcome, and could have a material adverse
effect on the Company. 


                                          15
<PAGE>

RISK MANAGEMENT.  In recent years, participants in the health care industry,
including physicians, nurses and other health care professionals, have been
subject to an increasing number of lawsuits alleging malpractice, product
liability and related legal theories, many of which involve large claims and
significant defense costs. Due to the nature of its business, the Company could
become involved in litigation regarding the telephone information given by its
registered nurses or those of its licensees with the risk of adverse publicity,
significant defense costs and substantial damage awards. The Company has
established policies and procedures that limit the information provided by its
registered nurses to that contained in its clinical algorithms and protocols and
in other approved reference sources. In connection with its teleservices
operations, the Company has a quality assurance program that includes real-time
audits of calls and post call reviews to monitor compliance with established
policies and procedures. Generally, clients review and approve the Company's
clinical algorithms, protocols and guidelines prior to program implementation
and do not modify them without medical approval. To date, the Company has not
been the subject of any claim involving either its clinical assessment systems,
the operation of its teleservicing centers or the operation by hospital or other
clients of on-site call centers. However, there can be no assurance that claims
will not be brought against the Company. Even if such claims ultimately prove to
be without merit, defending against them can be time consuming and expensive,
and any adverse publicity associated with such claims could have a material
adverse effect on the Company. 


                                          16
<PAGE>

                             PART II - OTHER INFORMATION

ITEM 6.        EXHIBITS AND REPORTS ON FORM 8-K

          a)   Exhibits:
     
     
     
EXHIBIT   DECRIPTION

2.1  (B)       Conformed Agreement and Plan of Reorganization by and among the
                    Registrant, Access Acquisition Corp. and Informed Access 
                    Systems, Inc. dated as of September 3,1996
3.1  (C)       Amended and Restated Certificate of Incorporation
3.2  (C)       Amended and Restated Bylaws
3.2  (D)       Certificate of Designation of Rights, Preferences and Privileges
                    of Series A Participating Preferred Stock of Access
                    Health, Inc. filed on March 13, 1997.
4.1  (C)       Specimen Stock Certificate
4.2  (A)       Registration Rights Agreement dated June 26, 1990 between
                    Registrant and certain parties named therein
4.3  (C)       Shareholder's Representation Statement and Registration Rights
                    Agreement dates as of November 25, 1996 between Registrant
                    and various investors
4.4  (C)       Registration Rights Agreement dated November 18, 1996
4.5  (D)       Form of Preferred Shares Rights Agreement, dated as of March 12,
                    1997 between the Company and The First National Bank of 
                    Boston, including exhibits
10.26 (E)      AHN Partners, L.P. 8% Convertible Subordinated Debenture due 2001

27             Financial Data Schedule.


          (A)  Incorporated by reference to Registrant's Form S-1 Registration
               No. 33-44604.
          (B)  Incorporated by reference to Registrant's Registration Statement
               on Form S-4 (No. 333-13931).
          (C)  Incorporated by reference to Registrant's Form 10-K for the year
               ended September 30, 1996.
          (D)  Incorporated by reference to Registrant's Registration Statement
               on Form 8-A filed March 13, 1997 (No. 000-19758). 
          (E)  Incorporated by reference to Registrant's Form 10-Q for the
               quarter ended March 31, 1997.
     
     
           b)  Reports on Form 8-K. No reports on Form 8-K were filed during
               the current quarter.


                                          17
<PAGE>

                                      Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.




                                    ACCESS HEALTH, INC.





Date:   February 17, 1998          /s/   Timothy H. Connor
                                   ----------------------------
                                   Timothy H. Connor
                                   Senior Vice President and Chief 
                                      Financial Officer (principal financial 
                                      officer of Registrant)


                                          18